Clinical trials
Medical Treatment clinical trials
Below are recruiting medical treatment clinical trials, each written for real people, not researchers. We’re tracking 1,130 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06942949Recruiting
Testing a new sound wave device for kidney stones
This study tests a new device that uses sound waves to break up kidney stones in the ureter. It may help people with a single stone of moderate size, as an alternative to surgery or standard shock wave treatment.
Phoenix, ArizonaAges 21 years+ - NCT07210086RecruitingPhase 2
PET scans to guide radiation for limited metastatic prostate cancer
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Duarte, CaliforniaAges 18 years+ - NCT07401524RecruitingPhase 4
Carbetocin to prevent bleeding after twin delivery
This trial tests whether a medication called carbetocin can help prevent heavy bleeding after giving birth to twins. If you are pregnant with twins and at least 23 weeks along, you may be able to join.
Ramat GanAges 18 years+ - NCT07453368RecruitingPhase 2
Orelabrutinib for relapsed or hard-to-treat AIHA
This trial tests a targeted pill called orelabrutinib for people with autoimmune hemolytic anemia (AIHA) that has come back or not responded to standard treatments. It may help control your immune system's attack on your red blood cells.
Beijing, Beijing MunicipalityAges 18–85 - NCT07645625RecruitingPhase 4
Pembrolizumab outcomes study in cervical cancer
This study tracks how well pembrolizumab works in people with cervical cancer that has come back, spread, or not gone away. It includes two groups: one for those currently on or starting the drug, and one for those who stop early due to a good response or side effects.
AmsterdamAges 18 years+ - NCT07496749Recruiting
Ketogenic diet for super-refractory seizure emergency
This trial tests if a high-fat, low-carb diet (ketogenic diet) can help stop seizures that have not responded to other treatments. It is for patients with a very severe, ongoing seizure emergency called super-refractory status epilepticus.
Hefei, AnhuiAges 14–80 - NCT07503652RecruitingPhase 4
Xeligekimab for moderate to severe palmoplantar pustulosis
This study tests a new drug (Xeligekimab) for people with moderate to severe palmoplantar pustulosis — a condition causing painful blisters on the hands and feet. It may be an option if other treatments haven't worked well.
ShenyangAges 18–75 - NCT07509645RecruitingPhase 3
Testing a new drug with clot removal for severe back-of-the-brain stroke
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
Suzhou, AnhuiAges 18 years+ - NCT06865846Enrolling by invitation
Treating high blood pressure in older adults
This study is testing a way to manage high blood pressure in older adults (65+) using remote monitoring at home. It aims to see if a personalized treatment plan helped by regular home blood pressure checks can get your numbers under control safely.
MoscowAges 65 years+ - NCT07286240RecruitingPhase 2
QL1706 with chemo and anlotinib for recurrent ovarian cancer
This trial tests a combination of a new immunotherapy drug (QL1706), chemotherapy, and a targeted therapy (anlotinib) for ovarian cancer that has come back after standard platinum treatment. The goal is to see if this triple therapy can shrink tumors or slow the cancer's return.
Guangzhou, GuangdongAges 18–70 - NCT06424912Recruiting
BPH treatment via vein connection for enlarged prostate
This trial tests a new treatment for enlarged prostate (BPH) that targets veins in the scrotum to improve urinary symptoms. It may be an option if you have both BPH and a varicocele and haven't had prior prostate surgery.
Panama City, Provincia de PanamáAges 40–75 - NCT07455019RecruitingPhase 2
Immunotherapy, targeted therapy, radiation, and chemo for limited spread esophageal cancer
This trial tests a combination of an immunotherapy drug (bemosubaymab), a targeted therapy (anlotinib), radiation therapy, and chemotherapy for patients with esophageal cancer that has spread to a limited number of spots (no more than 5). The goal is to see if this combination can shrink or control the cancer.
Nanjing, JiangsuAges 18 years+ - NCT07407738Recruiting
A trial of a shockwave device for calcified heart arteries
This trial tests a new device that uses sound waves to break up calcium deposits in heart arteries before placing a stent. It is for people with severely hardened arteries that are hard to treat with standard methods.
LyonAges 18 years+ - NCT03571334RecruitingPhase 2
Botox injections for nerve pain after chemotherapy in breast cancer
This trial studies whether botulinum toxin A (Botox) injections can reduce nerve pain caused by chemotherapy in people with breast cancer. It may help if your pain started soon after chemotherapy and fits the trial’s specific nerve-pain pattern.
Milwaukee, WisconsinAges 18 years+ - NCT04969354RecruitingPhase 1
CAIX-targeted CAR-T therapy for advanced kidney cancer
This early-phase study tests a lab-made immune treatment (CAIX-targeted CAR-T cells) for advanced kidney cancer that has not gone away with standard targeted therapy or immunotherapy. If eligible, the goal is to see if the treatment can safely shrink the cancer and improve outcomes.
Xuzhou, JiangsuAges 18–70 - NCT07656116RecruitingPhase 1
Oncolytic virus therapy for advanced solid tumors
This trial tests a virus-based treatment for people with advanced solid tumors that haven't responded to standard treatments. The virus is designed to infect and kill cancer cells while leaving healthy cells alone.
Langfang, HebeiAges 18 years+ - NCT05817955RecruitingPhase 2
Azacitidine plus ruxolitinib for higher-risk MDS/MPN
This Phase 2 study tests whether combining azacitidine and ruxolitinib can better control higher-risk bone marrow diseases (MDS/MPN, including CMML). It may help patients who are not good candidates for a stem cell transplant and who can safely take these medicines.
Nanjing, JiangsuAges 18–80 - NCT06949059RecruitingPhase 1/Phase 2
Hydromorphone for acute chest pain relief
This trial tests a quick-acting pain medicine (hydromorphone) given through a vein to treat severe chest pain. It may be an option for people experiencing acute pain who haven't been helped by other medicines.
Nanjing, JiangsuAges 18–64 - NCT07290140Recruiting
Balloon treatment for chronic sinusitis
This trial tests a balloon coated with a medicine (paclitaxel) to treat chronic sinusitis. It may help reduce inflammation and improve sinus drainage in adults with long-lasting sinus problems.
Birmingham, AlabamaAges 18 years+ - NCT07006532Recruiting
Tocilizumab for chronic active antibody-mediated rejection
This trial tests whether the drug tocilizumab can help treat chronic active antibody-mediated rejection after a kidney transplant. It is for people whose kidney function is still fairly good and who have certain findings on biopsy.
TehranAges 18 years+ - NCT07309900RecruitingPhase 1
Testing IASO208 for relapsed or hard-to-treat B-cell cancers
This trial tests a new treatment called IASO208 for people with certain types of B-cell lymphoma that have come back or not responded to standard treatments. It aims to see if the drug can help shrink tumors and control the cancer.
Wuhan, HubeiAges 18–75 - NCT07338097Enrolling by invitation
Comparing two eye injections for diabetic macular edema
This study tests whether one eye injection (aflibercept) works better than another (bevacizumab) for people with diabetic macular edema. Both are already used for this condition, and the goal is to see which provides better vision improvement.
Multan, Punjab ProvinceAges 30–60 - NCT07185061Recruiting
Sound treatment for chronic tinnitus
This study tests whether a special sound-based treatment can help people with chronic tinnitus (ringing in the ears). If your tinnitus has lasted more than six months and you don't have other ear or brain problems, you may be able to join.
Nanjing, JiangsuAges 18 years+ - NCT04046562Recruiting
Testing a teen pain-and-weight program
This trial studies a program meant to help teens manage weight when they also have ongoing muscle or joint pain. It may help by targeting pain feelings and supporting healthier weight habits at the same time.
Hartford, ConnecticutAges 12–18
Hear when a new Medical Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for medical treatment?
- Yes. Clin2 currently lists 1,130 recruiting medical treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a medical treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a medical treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.